WHO ICTRP trial
To study the effect of drug Eltrombopag with Filgrastim in bone marrow…
CTRI/2026/01/101630 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2026/01/101630 |
|---|---|
| Public title | To study the effect of drug Eltrombopag with Filgrastim in bone marrow transplant |
| Scientific title | A randomized controlled trial comparing the efficacy of Eltrombopag plus Filgrastim versus Filgrastim alone for peripheral blood stem cell mobilization in patients undergoing autologous stem cell transplant for lymphoma - NIL |
| Primary sponsor | Christian Medical College Vellore |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Countries | India |
| Conditions | Health Condition 1: D898- Other specified disorders involving the immune mechanism, not elsewhere classified |
| Interventions | Intervention1: Tab Eltrombopag + Inj Filgrastim With or without Inj Plerixafor: Tan Eltrombopag dose: 150mg once daily for 7 days Inj Filgrastim dose: 5mcg per kg twice daily for 4 days Control Intervention1: Inj Filgrastim With or without… |
| Registration date | Jan 20, 2026 |
| Target size | 100 |
| Secondary IDs | NIL |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: